Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5

Agenus Inc. , a leader in discovering and developing novel immunological agents to treat various cancers, today announced that the Compensation Committee of Agenus’ Board of Directors granted, as...

Related Keywords

Benny Johnson , Manuel Duenas , Compensation Committee , Agenus Inc , Compensation Committee Of Agenu Board Directors , Agenu Board , Market Access , Senior Medical Director , Equity Plan , Nasdaq Listing Rule , Grant Date , Markets ,